56) lity of the protective effects of caffeic acid phenethyl ester (CAPE) against PQ-ind |
57) Caffeic acid phenethyl ester decreases inflammatio |
58) line (control) group (n = 7), the caffeic acid phenethyl ester group (n = 7). |
59) ity of inflammation was milder in caffeic acid phenethyl ester group compared to non |
60) less myringosclerotic plaques in caffeic acid phenethyl ester group than in non-tre |
61) he tympanic membrane thickness of caffeic acid phenethyl ester group was much thinne |
62) As a result, caffeic acid phenethyl ester has potential prevent |
63) Fourth group received caffeic acid phenethyl ester intraperitoneally onc |
64) the histopathological effects of caffeic acid phenethyl ester on myringosclerosis d |
65) s of rats which were treated with caffeic acid phenethyl ester. |
66) Acid phosphatase activity increased signif |
67) Acid phosphatase activity was inhibited by |
68) a higher expression of tartrate-resistant acid phosphatase (TRAP) and the receptor a |
69) n apparent increase in tartrate resistant acid phosphatase (TRAP) positive staining |
70) Tartrate-resistant acid phosphatase (TRAP)-positive cell numb |
71) The serum level of tartrate-resistant acid phosphatase 5b, a marker of osteoclas |
72) gnificantly stimulated tartrate-resistant acid phosphatase activity in co-culture wi |
73) Sensitivity of acid phosphatase from Vigna aconitifolia s |
74) lored molybdate as a potent inhibitor for acid phosphatase in comparison with other |
75) dehydrogenase, glutathione peroxidase and acid phosphatase were not affected by GO t |
76) markably, even though informative nucleic acid is absent, prions may undergo rapid a |
77) Polysialic acid is an α2,8-linked N-acetylneuraminic |
78) Attachment to sialic acid is mediated by receptor binding prote |
79) gradation of the pharmaceutical clofibric acid is presented. |
80) Polysialic acid is produced by two complementary sial |
81) , but not the only, carrier of polysialic acid is the neural cell adhesion molecule |
82) Tannic acid is water-soluble polyphenol that is p |
83) Zoledronic acid is widely used in the treatment of os |
84) cyclododecane-N,N',N″,N‴-tetra acetic acid-DPhe1,Tyr3-octreotate) is used for di |
85) walked on a flat surface after zoledronic acid was administered for 2 years, 10 mont |
86) mited number of subjects, topical fusidic acid was found to delay wound healing by p |
87) adiation another conformer, II, of oxamic acid was generated, with cis orientation o |
88) Zoledronic acid was immediately discontinued in this |
|